Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy. - Wikidata - wikimedia - TriplyDB

Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy.

Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy.

http://www.wikidata.org/entity/Q37413491

about

Micro-NMR for rapid molecular analysis of human tumor samples Diagnosis of prostate cancer via nanotechnological approach Hybrid nanoparticles for combination therapy of cancer Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation Nanoinformatics knowledge infrastructures: bringing efficient information management to nanomedical research Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics.Direct Reading of Bona Fide Barcode Assays for Diagnostics with Smartphone Apps Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity.A fluorescent peroxidase probe increases the sensitivity of commercial ELISAs by two orders of magnitude Improved porous silicon microarray based prostate specific antigen immunoassay by optimized surface density of the capture antibody Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence Glucose oxidase-catalyzed growth of gold nanoparticles enables quantitative detection of attomolar cancer biomarkers.Universal Biotin-PEG-Linked Gold Nanoparticle Probes for the Simultaneous Detection of Nucleic Acids and Proteins.Strategic workshops on cancer nanotechnology Gold nanoparticles: preparation, properties, and applications in bionanotechnology Gold nanoparticles in chemical and biological sensing.Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations Nanotechnology in radiation oncology.Isolation and characterization of dendrimers with precise numbers of functional groups Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer.Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye.Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques.Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions.Multilayer polymer microchip capillary array electrophoresis devices with integrated on-chip labeling for high-throughput protein analysis.Attomolar detection of a cancer biomarker protein in serum by surface plasmon resonance using superparamagnetic particle labels.Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum.Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation.Direct measurement of DNA-mediated adhesion between lipid bilayers.Advancing the speed, sensitivity and accuracy of biomolecular detection using multi-length-scale engineering.A Highly Sensitive Porous Silicon (P-Si)-Based Human Kallikrein 2 (hK2) Immunoassay Platform toward Accurate Diagnosis of Prostate Cancer.Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR.Antibody colocalization microarray: a scalable technology for multiplex protein analysis in complex samples.Portable and quantitative detection of protein biomarkers and small molecular toxins using antibodies and ubiquitous personal glucose meters Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology A Wash-Free Homogeneous Colorimetric Immunoassay Method.Two types of nanoparticle-based bio-barcode amplification assays to detect HIV-1 p24 antigen.Highly efficient binding of paramagnetic beads bioconjugated with 100,000 or more antibodies to protein-coated surfaces.Biotargeted nanomedicines for cancer: six tenets before you begin Gold nanoparticle-based activatable probe for sensing ultralow levels of prostate-specific antigen.

P2860

Q24603587-D7651AFB-CFE4-47D2-9F43-22A10EC0DC81 Q26777322-AB0F49C2-C84B-4066-8B16-0188FAB608FD Q28086815-3745FE12-16DA-4AD3-BB65-E868AC0ED19C Q28391849-546EB3E2-6F19-4603-A209-C0FE92D63CC0 Q28392005-B51499F1-04BD-4F79-A6E7-5A256819AB4D Q28658443-C99B5524-294E-4C69-8C9E-AC4E1938D1D3 Q30391340-87A410A3-F231-4581-BDAC-D7511DFF86DA Q30656033-2B21F79D-8646-4254-8D00-5FCCE752C27A Q33561583-48BBFC3E-5CD5-4318-B01E-0F00E2C3D76D Q33572628-D7832688-4C81-484F-8893-89428B94DBEC Q33684005-8A8730F4-6AB4-44A2-8D24-7AB23BE96EA4 Q33759991-BDEAFF14-BE2B-4AB4-B4D6-FA255C59B999 Q33791805-74D6FD6B-88AA-4B73-BB32-5B4EE24DA60F Q33859313-1E0972E6-BCE7-4D51-854A-E57A1C9F59C1 Q33892023-AEDD5A04-702B-4FA2-9340-4AA23B49D6B6 Q33914355-F21BC2C4-2076-454C-B20A-C97902B50B5A Q33915917-F6F20492-8356-4D15-BE50-49E3B18B4CE9 Q34056386-423DF935-93C7-4814-965E-52F3C4FFD00F Q34124280-CA8DE4D5-C803-40E0-BEC0-B557522F83B7 Q34142960-5FED0AD8-9CD2-4FDE-89A0-48E3F1590AC0 Q34183785-FAE2BFCB-3FFD-4ABB-9E71-B252D43E1969 Q34308594-3EDF43E7-2260-4273-9C64-2C63FC2D17AE Q34486159-4C577FC8-5DCE-4936-BD5C-A78DE68C2B24 Q34666766-073D9C94-CD56-4E4C-AFC0-066AE54A626B Q34890156-F48DA343-7E8C-4C41-9ED4-A7BF120C5D07 Q34892088-C2EB46A5-413E-41E6-8948-DBDA8F565DAB Q35061782-5449CF8C-F5E9-44F1-9D27-D726239D6D0A Q35552351-EBBD6371-BBF2-40A0-896B-47E255954D22 Q35635386-83CF4B45-52DD-46EE-8316-EE1FF29E46BE Q35755590-57476153-0A6A-4211-A425-563DCEECBDB1 Q35785685-13A46B5F-3D5B-4556-8E2A-66CEAEBBF6EC Q35844968-CB1614A3-02C6-454C-85FF-C9C2919E8F19 Q35878752-E71F32CE-9F0F-4CCE-93BC-4EFFCA281601 Q35926118-B6DB5B48-7B3A-4FD2-B083-D0561D62B56A Q36108451-A09AF592-3170-4B62-B2AA-88DEECEC98E0 Q36372338-86524ABF-12E0-4656-8E08-5EB6E4D136E5 Q36394635-58E090C6-91B8-4642-AD6B-73FAD410D0A0 Q36445836-6A880853-EE7B-4D00-851C-818FA56BB94C Q36814280-B2F03F9E-0161-40AB-B86E-E523681D9018 Q36966723-F2E1B815-610F-4F78-B6EA-405DD6742B1B

P2860

Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy.

http://www.wikidata.org/entity/Q37413491

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nanoparticle-based bio-barcode ...... e after radical prostatectomy.

@en

Nanoparticle-based bio-barcode ...... e after radical prostatectomy.

@nl

type

label

Nanoparticle-based bio-barcode ...... e after radical prostatectomy.

@en

Nanoparticle-based bio-barcode ...... e after radical prostatectomy.

@nl

prefLabel

Nanoparticle-based bio-barcode ...... e after radical prostatectomy.

@en

Nanoparticle-based bio-barcode ...... e after radical prostatectomy.

@nl

P1433

Q37413491-E789963E-0C53-4C18-B817-F33EC047AC96

P1476

Q37413491-5942D0DB-177A-4771-B09E-C155451EBC42

P2093

Q37413491-008A6B33-DF91-42C6-90D7-5F0EF22190AE

Q37413491-1DBFC502-94A6-43A4-8619-9DF64EFBF3D8

Q37413491-4B972682-F540-4190-A8DC-06499117221F

Q37413491-5518E188-575B-4A18-A6E9-84BB818DEBCE

Q37413491-5EE52923-1F2C-402A-9543-1EF8E01C7039

Q37413491-87448908-00E7-4796-A677-A4580C7E4026

Q37413491-9E317A8B-2DBE-4C6C-901E-FE42105441D8

Q37413491-D24EC165-C510-4A1B-870F-3D73B828448C

Q37413491-E27450D9-4345-4E99-B016-6AB3752C2F2D

Q37413491-E41FBF34-15CC-449B-BA19-F943A28055E4

P2860

Q37413491-152C86CE-72F1-4550-9B88-7D4D1203BE8D

Q37413491-1B1F5939-C501-42F8-986F-1362D6F65FC3

Q37413491-1DEC275C-6017-4EA6-B840-FEA611A404E4

Q37413491-2F843CFD-89CC-40F5-B9BB-0AC47D7F433E

Q37413491-2FAD05AD-8223-4D3F-97E5-E98CCE1DA223

Q37413491-3CD3D361-6166-4749-95CA-3CF35980A558

Q37413491-3D8F6CDC-42F9-4582-96D6-4EB64CB916EA

Q37413491-43E17E4B-EB4B-4F5A-8DC4-BCAEE94935AF

Q37413491-4DA8254F-145D-4E3C-B1FE-4353B04B8419

Q37413491-4FD3C631-BAB5-4CFA-A1D5-9E2C9009B73F

P304

Q37413491-7CABC893-C206-4556-897D-8FFD4CCD01A8

P31

Q37413491-ABA964AE-A268-4A72-9C14-9E8FD143CC2A

P356

Q37413491-87C1F931-EB7C-4342-B585-D4C369A67299

P407

Q37413491-493C6D1C-0F70-4EC6-9FEF-494630407609

P433

Q37413491-F217C2BE-4044-4A04-B116-BFF4AB3E4DAE

P478

Q37413491-BC225090-EC90-4C77-B161-E3847C48ACC5

P50

Q37413491-DCA723C0-6253-4505-9295-8288B3FC94B0

P577

Q37413491-8BAB56AB-E4FC-410D-B41A-63E39FB373CF

P5875

Q37413491-85D2F073-CD06-4935-85AE-D098CF56F30E

P698

Q37413491-69C683AF-1A00-4728-9F9D-6F927D32E635

P921

Q37413491-4DF511A1-20AB-4C0E-8DE0-B19F9B1EE118

P932

Q37413491-1B635A32-4377-44B3-85DB-E56E75EB3820

P356

PNAS.0904719106

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Nanoparticle-based bio-barcode ...... e after radical prostatectomy.

@en

P2093

Anthony J Schaeffer

http://www.w3.org/2001/XMLSchema#string

Audrey D Thomas

http://www.w3.org/2001/XMLSchema#string

C Shad Thaxton

http://www.w3.org/2001/XMLSchema#string

Georg Bartsch

http://www.w3.org/2001/XMLSchema#string

Helmut Klocker

http://www.w3.org/2001/XMLSchema#string

Jae-Seung Lee

http://www.w3.org/2001/XMLSchema#string

Norm D Smith

http://www.w3.org/2001/XMLSchema#string

Robert Elghanian

http://www.w3.org/2001/XMLSchema#string

Savka I Stoeva

http://www.w3.org/2001/XMLSchema#string

Wolfgang Horninger

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

Patient-re ported complications and follow-up treatment after radical prostatectomy

Screening and prostate-cancer mortality in a randomized European study

Natural history of progression after PSA elevation following radical prostatectomy.

Human anti-animal antibody interferences in immunological assays.

Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease

Homogeneous detection of unamplified genomic DNA sequences based on colorimetric scatter of gold nanoparticle probes.

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.

P304

18437-18442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0904719106

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38022321

http://www.w3.org/2001/XMLSchema#string

P698

19841273

http://www.w3.org/2001/XMLSchema#string

P921

P932

2773980

http://www.w3.org/2001/XMLSchema#string